4th Circ. Questions Basis For Generic-Drug Injury Appeal

By Greg Ryan (December 16, 2013, 9:39 PM EST) -- Fourth Circuit judges on Thursday repeatedly interrupted an attorney's argument that failure-to-warn claims against Pliva Inc. aren't preempted by a landmark U.S. Supreme Court generic-drug liability ruling, questioning whether his client had the procedural grounding to make the appeal.

According to attorney Louis Bograd, the decision in Pliva v. Mensing does not bar allegations that Pliva failed to warn Shirley Gross, a now-deceased user of the heartburn drug metoclopramide, that the medication could cause the involuntary movement disorder tardive dyskinesia.

The Supreme Court held in Mensing that because generic-drug makers can't change their warning labels to differ from the label for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!